Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridoxamine and Bone Strength in T2DM
NCT03778580Completed
- Sponsor
- Columbia University
- Start
- Mar 2018
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Pyridoxamine with Placebo (2 arms). Primary endpoint: Bone formation in serum by P1NP at 12 months. Started Mar 2018; status: completed.
02
Drugs
pyridorin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03778580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03778580.